Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02667626 · ClinicalTrials.gov registry record · NA
Reproductive Health Survivorship Care Plan
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 182
- Enrollment target
NCT02667626 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 182 participants.
The verdict
NCT02667626, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 182 participants
- Enrollment target
Study Summary
The investigators propose to test the efficacy of the Reproductive Health Survivorship Care Plan (SCP-R), a novel survivorship care tool to meet the reproductive health needs of young breast cancer survivors (YBCS). Most YBCS undergo chemotherapy and/or endocrine therapy, treatments that impair ovarian function and result in significant reproductive health late effects. These late effects include symptoms of estrogen deprivation such as hot flashes, fertility concerns, limited contraception options and sexual problems. Together they have a major, negative impact on quality of life. Despite substantial research, treatment guidelines and clinical expertise on these issues, most YBCS and their healthcare providers have limited guidance on how best to manage these reproductive health late effects. The research team has generated a practical, accessible, evidence-based reproductive health survivorship care plan (the SCP-R) for YBCS and their providers to address this deficit in survivorship care. This clinical trial will test if YBCS who receive the web-based SCP-R are more likely than controls to improve on at least one of these reproductive health issues: hot flashes, sexual health, fertility concerns, and contraception.
Interventions
- OTHER Control
- OTHER Reproductive Health Survivorship Care Plan (SCPR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2015-03-25 |
| Est. Completion | 2019-01-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02667626
The ClinicalTrials.gov registry entry for NCT02667626 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT02667626 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02667626 about?
NCT02667626 is a clinical study titled "Reproductive Health Survivorship Care Plan". The investigators propose to test the efficacy of the Reproductive Health Survivorship Care Plan (SCP-R), a novel survivorship care tool to meet the reproductive health needs of young breast cancer survivors (YBCS). Most YBCS undergo chemotherapy and/or endocrine therapy, treatments that impair ovar...
What is the current status of trial NCT02667626?
This trial is currently completed. It is a NA study. The enrollment target is 182 participants. The study started on 2015-03-25. Estimated completion is 2019-01-24.
What interventions are being tested in trial NCT02667626?
The interventions under investigation include: Control (OTHER), Reproductive Health Survivorship Care Plan (SCPR) (OTHER).
Who is sponsoring clinical trial NCT02667626?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.